Provided by Tiger Trade Technology Pte. Ltd.

Dermata Therapeutics Inc

1.24
-0.0700-5.34%
Post-market: 1.22-0.0200-1.61%19:59 EDT
Volume:82.58K
Turnover:104.72K
Market Cap:3.52M
PE:-0.10
High:1.31
Open:1.27
Low:1.23
Close:1.31
52wk High:23.70
52wk Low:1.11
Shares:2.84M
Float Shares:1.98M
Volume Ratio:0.63
T/O Rate:4.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.1295
EPS(LYR):-80.3223
ROE:-203.36%
ROA:-96.45%
PB:0.89
PE(LYR):-0.02

Loading ...

Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Correspondence

Form CORRESP - Correspondence
Jul 08, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 02, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 30, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 28, 2023

Major Issues Report

8-K - Current report
Mar 28, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2023

Major Issues Report

8-K - Current report
Mar 16, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 16, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 16, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 15, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 14, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 14, 2023

Correspondence

CORRESP [Cover] - Correspondence